Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2026-01-02 @ 3:49 AM
Study NCT ID:
NCT01446159
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2011-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-28
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-12
First Submit QC Date:
None
Study First Post Date:
2011-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-30
Results First Submit QC Date:
None
Results First Post Date:
2018-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-22
Last Update Post Date:
2020-06-02
Last Update Post Date Type:
ACTUAL